Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.

Article  CAS  PubMed  Google Scholar 

Crawley WT, Jungels CG, Stenmark KR, et al. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox Biol. 2022;51: 102271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang M, Zhu X, Wu J, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19. Front Immunol. 2021;12: 791983.

Article  CAS  PubMed  Google Scholar 

Yanai H, Adachi H, Hakoshima M, et al. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petreski T, Ekart R, Hojs R, et al. Hyperuricemia, the heart, and the kidneys - to treat or not to treat? Ren Fail. 2020;42(1):978–86.

Article  PubMed  PubMed Central  Google Scholar 

O’Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14.

Article  PubMed  Google Scholar 

Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020;28(4):O1-o58.

Article  PubMed  Google Scholar 

Zhang X, Zhu C, Gao J, et al. Gender difference in the relationship between serum uric acid reduction and improvement in body fat distribution after laparoscopic sleeve gastrectomy in Chinese obese patients: a 6-month follow-up. Lipids Health Dis. 2018;17(1):288.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen X, You H, Wei L, et al. Correlation between impaired sensitivity to thyroid hormones and serum uric acid in female patients with obesity and after laparoscopic sleeve gastrectomy. Endocr Pract. 2024;30(5):417–23.

Article  PubMed  Google Scholar 

Hisatome I, Ichida K, Mineo I, et al. Japanese society of gout and uric & nucleic acids 2019 guidelines for management of hyperuricemia and gout. 3rd ed. Gout Uric Nucleic Acids. 2020;44(Supplement):sp-1–sp-40.

Sisik A, Basak F. Presurgical predictive factors of excess weight loss after laparoscopic sleeve gastrectomy. Obes Surg. 2020;30(8):2905–12.

Article  PubMed  Google Scholar 

Chu Y, Widjaja J, Hong J, et al. Effect of sleeve gastrectomy on plasma thioredoxin-interacting protein (TXNIP). Obes Surg. 2021;31(11):4829–35.

Article  PubMed  Google Scholar 

Liu DM, Jiang LD, Gan L, et al. Association between serum uric acid level and body mass index in sex- and age-specific groups in Southwestern China. Endocr Pract. 2019;25(5):438–45.

Article  PubMed  Google Scholar 

Liu M, Cao B, Luo Q, et al. A gender-, age-, and weight status-specific analysis of the high prevalence of hyperuricemia among Chinese children and adolescents with obesity. Diabetes Metab Syndr Obes. 2024;17:381–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCormick N, O’Connor MJ, Yokose C, et al. Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional mendelian randomization. Arthritis Rheumatol. 2021;73(11):2096–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao M, Liu J, Chen X, et al. Correlation between serum uric acid and body fat distribution in patients with MAFLD. BMC Endocr Disord. 2023;23(1):204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoque KM, Dixon EE, Lewis RM, et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat Commun. 2020;11(1):2767.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, An K, Mou X, et al. Effect of urate-lowering therapy on the progression of kidney function in patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. Front Pharmacol. 2021;12: 795082.

Article  PubMed  Google Scholar 

You H, Ma H, Wang X, et al. Association between liver-type fatty acid-binding protein and hyperuricemia before and after laparoscopic sleeve gastrectomy. Front Endocrinol (Lausanne). 2022;13: 993137.

Article  PubMed  Google Scholar 

Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg. 2015;25(1):19–26.

Article  PubMed  Google Scholar 

Menenakos E, Doulami G, Tzanetakou IP, et al. The use of serum uric acid concentration as an indicator of laparoscopic sleeve gastrectomy success. Int Surg. 2015;100(1):173–9.

Article  PubMed  PubMed Central  Google Scholar 

Katsogridaki G, Tzovaras G, Sioka E, et al. Hyperuricemia and acute gout after laparoscopic sleeve gastrectomy. Clin Obes. 2019;9(2): e12296.

Article  PubMed  Google Scholar 

Davoudi Z, Shokuhi Sabet A, Toreyhi H, et al. Impact of sleeve gastrectomy on uric acid levels in patients with obesity: a comparative study. Obes Surg. 2024;34(7):2704–10.

Article  PubMed  Google Scholar 

Birben B, Akkurt G, Tez M, et al. Long-term impact of sleeve gastrectomy on serum uric acid levels. Turk J Med Sci. 2023;53(1):206–10.

Article  PubMed  Google Scholar 

Ishizaka N, Ishizaka Y, Toda A, et al. Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals. J Rheumatol. 2010;37(2):410–6.

Article  CAS  PubMed  Google Scholar 

Oberbach A, Neuhaus J, Schlichting N, et al. Sleeve gastrectomy reduces xanthine oxidase and uric acid in a rat model of morbid obesity. Surg Obes Relat Dis. 2014;10(4):684–90.

Article  PubMed  Google Scholar 

Najafi S, Bahrami M, Butler AE, et al. The effect of glucagon-like peptide-1 receptor agonists on serum uric acid concentration: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(8):3627–37.

Article  CAS  PubMed  Google Scholar 

Brown E, Wilding JPH, Barber TM, et al. Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities. Obes Rev. 2019;20(6):816–28.

Article  CAS  PubMed  Google Scholar 

Ji L, Jiang H, An P, et al. IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1b study. EClinicalMedicine. 2021;39: 101088.

Article  PubMed  PubMed Central  Google Scholar 

Okamoto A, Yokokawa H, Nagamine T, et al. Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. J Diabetes Metab Disord. 2021;20(2):2121–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Qian H, Cui Y, et al. Associations between estradiol and hyperuricemia and the mediating effects of TC, TG, and TyG: NHANES 2013–2016. Front Endocrinol (Lausanne). 2024;15:1422470.

Article  PubMed  Google Scholar 

Liu L, Zhao T, Shan L, et al. Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway. Nutr Metab (Lond). 2021;18(1):63.

Article  CAS